December 5, 2024
  1. Home
  2. Finance
  3. Cassava Sciences’ stock…

Cassava Sciences’ stock craters after Alzheimer’s disease trial fails to meet its goals

Cassava Sciences’ stock craters after Alzheimer’s disease trial fails to meet its goals

Cassava Sciences’ stock craters after Alzheimer’s disease trial fails to meet its goals

The biotech says it will discontinue a second trial but will still offer full analyses of the data.

Hendrick

https://www.financialgazette.co.uk

Subscribe to our Newsletter

Be the first to receive the latest buzz contests & more!

Follow us:

Quick links

News category

Our sites

Contact us

© 2024, Financialgazette. All rights reserved.